Video Title: Lightning Round: I want you to own D-Wave Quantum, says Jim Cramer
Video ID: Ldy5uCEcctQ
Video URL: https://www.youtube.com/watch?v=Ldy5uCEcctQ
Export Date: 2025-10-25 23:18:43
Channel: CNBC Television
Format: plain
================================================================================

📹 Video Information:

Title: Lightning Round: I want you to own D-Wave Quantum, says Jim Cramer
Duration: 04:36

Overview
This appears to be a transcript from Jim Cramer's "Lightning Round" segment where he quickly answers viewer questions about various stocks. The format involves rapid-fire stock recommendations and brief analysis of different companies brought up by callers from various locations.

Main Topics Covered
• Stock recommendations
• Mining companies (Agnico Eagle)
• Pharmaceutical stocks (Bristol-Myers)
• Cryptocurrency/fintech companies (Clean Spark)
• Dividend stocks (Flex LNG)
• D-Wave (quantum computing)

Key Takeaways & Insights
• Cramer suggests being selective with stock picks in the current market
• High dividend yields should be scrutinized for potential underlying issues
• Some speculative stocks can be worth considering if treated as speculation
• Market conditions appear to be favorable for certain stocks to make significant moves on positive news

Actionable Strategies
• Consider Agnico Eagle instead of New Gold for mining exposure
• Hold Bristol-Myers but monitor their central nervous system drug development
• Treat Clean Spark as a speculative play only
• Research thoroughly when encountering unusually high dividend yields

Specific Details & Examples
• Bristol-Myers described as "never seen it this cheap"
• Clean Spark mentioned as having 12 analyst buy ratings
• Flex LNG noted for its 13% dividend yield
• D-Wave described as capable of 10-point moves on positive news

Warnings & Common Mistakes
• Caution against assuming high dividends are automatically safe
• Warning about speculative nature of certain stocks like Clean Spark
• Need for due diligence when stocks appear unusually cheap

Resources & Next Steps
• Segment sponsored by Charles Schwab
• Suggestion to research more deeply into companies with unusually high dividends
• Importance of following up on specific company developments (like Bristol-Myers' CNS drug)